Mode
Text Size
Log in / Sign up

AI models demonstrate high diagnostic accuracy for identifying osteonecrosis of the femoral head in imaging dataArtificial intelligence shows high accuracy in detecting hip bone death

AI-generated summary of the cited source, checked by automated accuracy review. How we work

Key Takeaway
Note that AI models show high diagnostic accuracy for ONFH, but results are limited by retrospective designs.

This meta-analysis evaluates the diagnostic performance of artificial intelligence models used to identify osteonecrosis of the femoral head (ONFH) across 12 studies involving 16,189 hip joints. The analysis synthesizes data on sensitivity, specificity, and Diagnostic Odds Ratio (DOR) across various imaging modalities.

Key findings include a pooled sensitivity of 0.91 (95% CI 0.87-0.95) and a pooled specificity of 0.95 (95% CI 0.93-0.96). The SROC AUC was reported at 0.97 (95% CI 0.95-0.98). Furthermore, MRI-based models showed a DOR of 382 (95% CI 220-665), which is higher than the DOR of 106 (95% CI 60-190) observed for x-ray-based models. The analysis also noted that internally validated models had a DOR of 230 (95% CI 104-510), while externally validated models showed a lower DOR of 129 (95% CI 51-329).

Limitations include a small number of included studies, predominantly retrospective designs, and a lack of adequate external validation. Clinical translation is cautioned by the authors due to these methodological constraints and high heterogeneity (I^2 72%).

How this fits prior evidence

This meta-analysis addresses a gap in diagnostic tools for osteonecrosis of the femoral head. While prior evidence explored surgical approaches, stem cell therapies, and theoretical models for steroid-induced osteonecrosis, this study specifically evaluates the accuracy of AI models in identifying the condition from medical imaging.

When someone suffers from osteonecrosis of the femoral head, their hip joint begins to break down. Detecting this early is vital for treatment. A large review of 12 studies involving over 16,000 hip joints found that artificial intelligence (AI) models are highly accurate at spotting this condition in medical images.

The data showed that these AI tools had a high sensitivity of 0.91 and a specificity of 0.95. This means they are very effective at correctly identifying the disease while also ruling it out for healthy patients. Specifically, MRI-based models performed significantly better than those using X-rays.

While the results are promising, there are important notes to keep in mind. The researchers noted that much of the evidence comes from older study designs and lacks enough outside testing. Because of these limitations, experts suggest we should be cautious about how quickly these tools can be used in every clinic.

What this means for you:
AI models show high accuracy in identifying hip bone death, though more independent testing is needed.

Common questions

How accurate is AI at finding this hip condition?

The study found that AI models had a high sensitivity of 0.91 and a specificity of 0.95. This means the tools are very effective at correctly identifying the condition in medical images while also accurately ruling it out for those without the disease.

Is MRI better than X-ray for this diagnosis?

Yes, the data suggests that MRI-based models performed better. They had a Diagnostic Odds Ratio of 382, which is significantly higher than the 106 reported for X-ray-based models.

Are these AI tools ready to use in every clinic?

While the accuracy is high, experts advise caution. The current evidence is limited by a small number of studies and a lack of external validation, meaning more testing is needed before they are standard for everyone.

Study Details

Study typeMeta analysis
EvidenceLevel 1
PublishedAug 2026
View Original Abstract ↓
BACKGROUND: Osteonecrosis of the femoral head (ONFH) is a common cause of hip disability in clinical practice. Early and accurate diagnosis can delay or even halt disease progression. In recent years, AI models based on medical imaging have been increasingly applied to the diagnosis of ONFH; however, a systematic evaluation of their diagnostic accuracy remains lacking. OBJECTIVE: This study aims to synthesize the overall diagnostic accuracy of medical imaging-based AI models for ONFH and to inform clinical decision-making. METHODS: This systematic review was conducted in accordance with the PRISMA-DTA (Preferred Reporting Items for Systematic Reviews and Meta-Analyses of Diagnostic Test Accuracy Studies) guidelines and was prospectively registered in PROSPERO (CRD420261307216). We searched PubMed, Embase, Cochrane Library, and Web of Science up to March 8, 2026. Studies developing or validating AI models for ONFH diagnosis using imaging data were eligible. Risk of bias was assessed using the QUADAS-2 tool. Sensitivity, specificity, positive likelihood ratio (PLR), negative likelihood ratio (NLR), and diagnostic odds ratio (DOR) were pooled using a bivariate mixed-effects model, and a summary receiver operating characteristic (SROC) curve was constructed. Subgroup analyses were stratified by imaging modality (x-ray vs MRI), disease stage (early-stage ONFH vs all-stage ONFH), diagnostic criteria (Association Research Circulation Osseous [ARCO] staging vs other criteria), control group type (healthy controls vs disease controls), validation method (internal validation vs external validation), center type (single-center vs multicenter), and model type (deep learning vs machine learning). Meta-regression was performed to quantify the contribution of each covariate to between-study heterogeneity. Sensitivity analysis and Deeks asymmetry test assessed the robustness of the results and publication bias. Clinical utility was evaluated using the Fagan nomogram. RESULTS: A total of 12 studies comprising 16,189 hip joints were included. The pooled sensitivity was 0.91 (95% CI 0.87-0.95), the pooled specificity was 0.95 (95% CI 0.93-0.96), and the SROC AUC was 0.97 (95% CI 0.95-0.98). Substantial between-study heterogeneity was observed (²=72%, 95% CI 38%-100%). Subgroup analysis showed that MRI-based models yielded a higher diagnostic odds ratio (DOR; 382, 95% CI 220-665) than x-ray-based models (106, 95% CI 60-190), while models that underwent external validation had a lower DOR (129, 95% CI 51-329) than those with only internal validation (230, 95% CI 104-510). Meta-regression identified imaging modality as the primary source of heterogeneity, explaining 92.1% of the between-study variance. CONCLUSIONS: AI models demonstrate high diagnostic accuracy in imaging-based ONFH diagnosis. However, the current evidence is constrained by the limited number of included studies, predominantly retrospective designs, and a lack of adequate external validation, and should therefore be interpreted with caution. Future research should adopt multicenter prospective designs, standardize reference standards, and implement rigorous external validation to facilitate clinical translation.
Free Newsletter

Clinical research that matters. Delivered to your inbox.

Join thousands of clinicians and researchers. No spam, unsubscribe anytime.